Innovator Semaglutide 2.4 mg: A Benchmark Therapy for Chronic Weight Management – CME by Novo (Wegovy)

Dr. Sudhir Bhandari participated in CME by Novo (Wegovy) on 23 June 2026, contributing to the programme as speaker / faculty. His session focused on Innovator Semaglutide 2.4 mg: A Benchmark Therapy for Chronic Weight Management, reflecting his continuing engagement in medical education, clinical dialogue and professional knowledge-sharing.